Editorial: quadruple therapy for H. pylori eradication is better than triple therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 694-695

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: clarithromycin dose for H. pylori therapy remains unresolved – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 632-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing

By Sivri Bulent   Simsek Ilkay   Hulagu Saadettin   Kadayifci Abdurrahman   Tozun Nurdan   Akarsu Mesut   Uraz Suleyman   Savas M. Cemil   Koruk Mehmet   Bozbas Aysun  

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1301-1307

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 768-775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 581-589

John Wiley & Sons Inc

Access to resources Recommend Favorite